These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24167374)
1. Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein. Boshtam M; Razavi AE; Pourfarzam M; Ani M; Naderi GA; Basati G; Mansourian M; Dinani NJ; Asgary S; Abdi S Dis Markers; 2013; 35(4):273-80. PubMed ID: 24167374 [TBL] [Abstract][Full Text] [Related]
2. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins. Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725 [TBL] [Abstract][Full Text] [Related]
3. Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects. Kim DS; Maden SK; Burt AA; Ranchalis JE; Furlong CE; Jarvik GP Lipids Health Dis; 2013 Dec; 12():183. PubMed ID: 24330840 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study. Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975 [TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood. Gugliucci A; Numaguchi M; Caccavello R; Kimura S Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935 [TBL] [Abstract][Full Text] [Related]
7. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin. Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287 [TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654 [TBL] [Abstract][Full Text] [Related]
9. Effect of dietary lipids on paraoxonase-1 activity and gene expression. Ferretti G; Bacchetti T Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836 [TBL] [Abstract][Full Text] [Related]
10. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment. Marsillach J; Aragonès G; Mackness B; Mackness M; Rull A; Beltrán-Debón R; Pedro-Botet J; Alonso-Villaverde C; Joven J; Camps J Lipids Health Dis; 2010 May; 9():46. PubMed ID: 20470383 [TBL] [Abstract][Full Text] [Related]
11. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. Gugliucci A Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342 [TBL] [Abstract][Full Text] [Related]
12. High density lipoprotein subfractions and paraoxonase 1 in children. Muchová J; Andrezálová L; Oravec S; Nagyová Z; Garaiova I; Ďuračková Z Acta Biochim Pol; 2016; 63(3):555-63. PubMed ID: 27262841 [TBL] [Abstract][Full Text] [Related]
13. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Deakin S; Moren X; James RW Atherosclerosis; 2005 Mar; 179(1):17-25. PubMed ID: 15721005 [TBL] [Abstract][Full Text] [Related]
14. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function. James RW; Deakin SP Adv Exp Med Biol; 2010; 660():173-81. PubMed ID: 20221880 [TBL] [Abstract][Full Text] [Related]
15. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. Rock W; Rosenblat M; Miller-Lotan R; Levy AP; Elias M; Aviram M J Agric Food Chem; 2008 Sep; 56(18):8704-13. PubMed ID: 18759451 [TBL] [Abstract][Full Text] [Related]
16. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies. Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity. Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278 [TBL] [Abstract][Full Text] [Related]
18. [High-density lipoproteins (HDL) size and composition are modified in the rat by a diet supplemented with "Hass" avocado (Persea americana Miller)]. Pérez Méndez O; García Hernández L Arch Cardiol Mex; 2007; 77(1):17-24. PubMed ID: 17500188 [TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance. Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439 [TBL] [Abstract][Full Text] [Related]
20. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]